Stay in the Game with Video

Sports is a Major Industry, and Sporting Venues Make Up a Huge Portion of the Business

Those who design and manage sports and entertainment facilities around the globe understand the importance of creating an atmosphere that keeps fans excited, engaged and, of course, spending more money. According to a recent study by CreditCards.com, fans spend $56 billion annually to attend sporting events, including the cost of tickets, transportation, souvenirs, food, and drinks. However, the increasing cost and time commitment of visiting sports venues have contributed to stagnated or slightly decreased stadium attendance across many leagues in recent years. In addition, venues find themselves competing with improved home viewing options powered by better camera angles, the growth of AR/VR, and multiplatform multimedia experiences.

In today’s competitive environment, if you build it, they may not necessarily come. Stadiums need to invest in the differentiators that will draw in new generations of fans to increase ticket sales and in-stadium purchases.

To Compete with Home Viewing, Sports Venues Need to Expand their AV Capabilities

To create a memorable fan experience, stadiums must upgrade their TVs, add more screens, and incorporate video walls. By distributing sports programming throughout a stadium, these sites have the means to increase food and beverage sales by keeping customers happy and engaged while they’re waiting in long concession lines, with marketing messages that can be tailored to the specific audience and changed at a moment’s notice. Digital signage can be used to communicate basic information, such as the location of bathrooms and exits; but it can also create new sources of revenue by featuring paid marketing messages from advertisers. In fact, switching to digital signage allowed the Pittsburgh Penguins to achieve a 300% increase in concourse advertising and sponsorship revenue, while the Denver Broncos increased their concourse signage revenue by 50%.

Read full article.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More